Bausch Health Companies Inc
NYSE:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
NYSE:BHC
Watchlist
Price: 5.59 USD -1.24% Market Closed
Market Cap: $2.1B

Operating Margin

15%
Current
Improving
by 1.6%
vs 3-y average of 13.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15%
=
Operating Income
$2.1B
/
Revenue
$10B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15%
=
Operating Income
$2.1B
/
Revenue
$10B

Peer Comparison

Country Company Market Cap Operating
Margin
CA
Bausch Health Companies Inc
TSX:BHC
2.9B CAD
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...
FR
Sanofi SA
PAR:SAN
95.7B EUR
Loading...

Market Distribution

Higher than 76% of companies in Canada
Percentile
76th
Based on 4 855 companies
76th percentile
15%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

Bausch Health Companies Inc
Glance View

Bausch Health Companies Inc. stands as a prominent player in the global healthcare arena, with its roots stretching back over a century. Originally known as Valeant Pharmaceuticals, the firm has undergone significant transformation, focusing on a diverse array of health-related products and innovations. The company operates primarily in three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. Each of these divisions articulates its commitment to enhancing patients' lives through high-quality products that address the complex challenges of eye care, gastroenterology, and dermatology, respectively. The Bausch + Lomb sector, named after its foundational company, is recognized globally for its wealth of eye health products, including contact lenses, lens care products, and ophthalmic pharmaceuticals. This sector is integral to Bausch Health's revenue stream, contributing significantly through its diverse portfolio of over-the-counter and prescription offerings. At its core, Bausch Health has honed a business model centered around acquiring and developing specialty pharmaceuticals and health-enhancing technologies. Through strategic acquisitions, partnerships, and internal research, the company curates a vast pipeline of treatments and solutions. Revenue generation for Bausch Health is intrinsically linked to its global market footprint, operating in more than 100 countries. Sales teams across these regions work diligently to ensure that healthcare professionals and consumers alike have access to their products. Meanwhile, the company's commitment to innovation helps it remain responsive in rapidly evolving medical fields. The sales and marketing strategies are finely tuned to address regional disparities, leveraging local insights to maximize market penetration and bolster growth. Ultimately, Bausch Health Companies Inc. thrives by bridging high-quality health solutions with unmet global needs, seeking to leave a lasting impact on the lives it touches.

BHC Intrinsic Value
58.68 USD
Undervaluation 90%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15%
=
Operating Income
$2.1B
/
Revenue
$10B
What is Bausch Health Companies Inc's current Operating Margin?

The current Operating Margin for Bausch Health Companies Inc is 15%, which is above its 3-year median of 13.4%.

How has Operating Margin changed over time?

Over the last 3 years, Bausch Health Companies Inc’s Operating Margin has increased from 12.7% to 15%. During this period, it reached a low of 11.8% on Mar 31, 2023 and a high of 14.9% on Sep 30, 2025.

Back to Top